+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hemophilia Treatment Market by Type, by Product, and by Therapy: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025

  • ID: 4854537
  • Report
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

The report covers a forecast and an analysis of the hemophilia treatment market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes the drivers and restraints of the hemophilia treatment market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hemophilia treatment market on a global and regional level.

In order to give the users of this report a comprehensive view of the hemophilia treatment market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the hemophilia treatment market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new Type launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the hemophilia treatment market on a global and regional basis.

The study provides a decisive view of the hemophilia treatment market by segmenting it based on type, product, therapy, and region. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some key players operating in the global hemophilia treatment market are Pfizer, Baxalta, Baxter International, CSL Ltd., Octapharma, Grifols, Novo Nordisk, Kedrion, Bayer, Biogen Idec, and Hospira.

This report segments the global hemophilia treatment market into:

Global Hemophilia Treatment Market: By Type

  • Hemophilia A
  • Hemophilia B
  • Hemophilia C

Global Hemophilia Treatment Market: By Product

  • Recombinant Coagulation Factor Concentrates
  • Plasma Derived Coagulation Factor Concentrates
  • Antifibrinolytic Agents
  • Desmopressin

Global Pediatrics Healthcare Market: By Therapy

  • Replacement Therapy
  • Gene Therapy

Global Hemophilia Treatment Market: By Region

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Hemophilia Treatment Market Revenue, 2016-2025 (USD Million)
    • 2.2. Global Hemophilia Treatment Market: Snapshot
  • Chapter 3. Hemophilia Treatment Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Hemophilia Treatment Market Drivers: Impact analysis
      • 3.2.2. Increasing incidences of bleeding disorders and their rising severity
      • 3.2.3. Technological Advancements
    • 3.3. Market Restraints
      • 3.3.1. Limited access to treatment
    • 3.4. Opportunities
      • 3.4.1. Advancements in gene therapy
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Type
      • 3.6.2. Market attractiveness analysis, by Product
      • 3.6.3. Market attractiveness analysis, by Therapy
      • 3.6.4. Market attractiveness analysis, by Region
  • Chapter 4. Global Hemophilia Treatment Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Hemophilia Treatment Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  • Chapter 5. Global Hemophilia Treatment Market - Type Analysis
    • 5.1. Global Hemophilia Treatment Market: Type overview
      • 5.1.1. Global Hemophilia Treatment Market revenue share, by Type, 2018 and 2025
    • 5.2. Hemophilia A
      • 5.2.1. Global Hemophilia Treatment Market for Hemophilia A, 2016-2025 (USD Million)
    • 5.3. Hemophilia B
      • 5.3.1. Global Hemophilia Treatment Market for Hemophilia B, 2016-2025 (USD Million)
    • 5.4. Hemophilia C
      • 5.4.1. Global Hemophilia Treatment Market for Hemophilia C, 2016-2025 (USD Million)
  • Chapter 6. Global Hemophilia Treatment Market - Product Analysis
    • 6.1. Global Hemophilia Treatment Market: Product overview
      • 6.1.1. Global Hemophilia Treatment Market revenue share, by Product, 2018 and 2025
    • 6.2. Recombinant Coagulation Factor Concentrates
      • 6.2.1. Global Hemophilia Treatment Market for Recombinant Coagulation Factor Concentrates, 2016-2025 (USD Million)
    • 6.3. Plasma Derived Coagulation Factor Concentrates
      • 6.3.1. Global Hemophilia Treatment Market for Plasma Derived Coagulation Factor Concentrates, 2016-2025 (USD Million)
    • 6.4. Antifibrinolytic Agents
      • 6.4.1. Global Hemophilia Treatment Market for Antifibrinolytic Agents, 2016-2025 (USD Million)
    • 6.5. Desmopressin
      • 6.5.1. Global Hemophilia Treatment Market for Desmopressin, 2016-2025 (USD Million)
  • Chapter 7. Global Hemophilia Treatment Market - Therapy Analysis
    • 7.1. Global Hemophilia Treatment Market: Treatment overview
      • 7.1.1. Global Hemophilia Treatment Market revenue share, by Treatment, 2018 and 2025
    • 7.2. Replacement Therapy
      • 7.2.1. Global Hemophilia Treatment Market for Replacement Therapy, 2016-2025 (USD Million)
    • 7.3. Gene Therapy
      • 7.3.1. Global Hemophilia Treatment Market for Gene Therapy, 2016-2025 (USD Million)
  • Chapter 8. Global Hemophilia Treatment Market - Regional Analysis
    • 8.1. Global Airport Logistics System: Regional overview
      • 8.1.1. Global Hemophilia Treatment Market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
      • 8.2.2. North America Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
      • 8.2.3. North America Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.2.4.2. The U.S. Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.2.4.3. The U.S. Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.2.5.2. Rest of North America Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.2.5.3. Rest of North America Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
      • 8.3.2. Europe Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
      • 8.3.3. Europe Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.3.4.2. Germany Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.3.4.3. Germany Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. UK Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.3.5.2. UK Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.3.5.3. UK Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.3.6.2. France Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.3.6.3. France Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.3.7.2. Rest of Europe Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.3.7.3. Rest of Europe Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
      • 8.4.3. Asia Pacific Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.4.4.2. China Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.4.4.3. China Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.4.5.2. Japan Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.4.5.3. Japan Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.4.6.2. India Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.4.6.3. India Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.4.7.2. Rest of Asia Pacific Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.4.7.3. Rest of Asia Pacific Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
      • 8.5.2. Latin America Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
      • 8.5.3. Latin America Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.5.4.2. Brazil Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.5.4.3. Brazil Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
        • 8.5.5.2. Rest of Latin America Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
        • 8.5.5.3. Rest of Latin America Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
      • 8.6.2. The Middle East and Africa Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
      • 8.6.3. The Middle East and Africa Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
  • Chapter 9. Company Profile
    • 9.1. Pfizer
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Type Portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Baxalta
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Type Portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Baxter International
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Type Portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. CSL Ltd.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Type Portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Octapharma
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Type Portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Grifols
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Type Portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Novo Nordisk
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Type Portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Kedrion
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Type Portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Bayer
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Type Portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Biogen Idec
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Type Portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. Hospira
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Type Portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll